Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

CPCS results in over 100k patients referred to community pharmacies

The Community Pharmacist Consultation Service (CPCS) has seen more than 100,000 patients referred from NHS 111 into community pharmacies in its first two months.

Since its launch on October 29, 114,275 patients with minor illnesses or in need or urgent medicines supply in England have been referred by NHS 111 for a consultation with a community pharmacist.

Of these referrals, 64,067 were requests for urgent medication, for conditions such as diabetes or asthma. The remaining 50,208 referrals were patients with minor illnesses who required clinical advice, the Department of Health and Social Care (DH) said yesterday (January 12).

The north-west of England saw the highest number of referrals, followed by the north-east and Yorkshire (see full table below):

Region
Minor illness
Urgent medicines supply
Total referrals
North-west
7,710
13,262
20,972
North-east and Yorkshire
8,525
11,525
20,050
South-east
6,141
10,808
16,949
Midlands
9,091
7,106
16,197
London
5,528
7,384
12,912
East of England
7,451
5,311
12,762
South-west
3,375
4,662
8,037
Out of regions
2,387
4,009
6,396
Grand total
50,208
64,067
114,275

The service will be expanded to include referrals from general practice by the end of 2020, subject to the evaluation of pilots, the DH said.

So far, 10,610 of England’s 11,500 community pharmacies have signed up to provide the service. Pharmacies receive £14 for each resulting consultation.

Hancock: Pharmacy is integral part of NHS

Responding to the CPCS figures, health secretary Matt Hancock said community pharmacy is an “integral and trusted” part of the NHS.

The DH wants patients with minor illnesses to “think ‘pharmacy first’”, said Mr Hancock, who expects to see pharmacists “ready and able to do much more” to keep people healthy and relieve pressure on hospitals.

The ‘pharmacy first’ approach “makes life easier for patients and will help reduce pressure in the NHS”, he added.

CPCS “unlocks full potential” of pharmacy

England’s deputy chief pharmaceutical officer Bruce Warner said the CPCS has been a “fantastic success”, which “unlocks the full potential of community pharmacy”.

Patients have said they are “satisfied with the service they received”, and the number of referrals “shows how well it is working”, he added.

PSNC: Patients receive convenient option

Meanwhile, Pharmaceutical Services Negotiating Committee (PSNC) chief executive Simon Dukes pointed out that the CPCS has been a “long time coming”, and offers patients a “convenient option for receiving high quality and clinically safe care and advice”.

Mr Dukes is “delighted” that so many pharmacies are offering the service and “taking pressure off NHS colleagues” in the process, he added.

Watch Andre Yeung, one of the architects behind the pilot that inspired the CPCS, answer pharmacists’ questions about the service in last's month C+D webinar (skip to 8.45 minutes for the start of​ the Q&A):

Have you received many referrals from NHS 111 as part of the CPCS?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD006279

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel